Cargando…

The infectious origin of the antiphospholipid syndrome: induction by passive transfer of anti-β2GPI antibodies induced by common bacteria

Detalles Bibliográficos
Autores principales:	Blank, M, Krause, I, Fridkin, M, Keller, N, Kopolovic, J, Goldberg, I, Tobar, A, Shoenfeld, Y
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833581/ http://dx.doi.org/10.1186/ar644

Ejemplares similares

The infectious origin of the antiphospholipid syndrome: induction by passive transfer of anti- β2GPI Abs induced by common bacteria
por: Blank, M, et al.
Publicado: (2001)

Neurological Dysfunction Associated with Antiphospholipid Syndrome: Histopathological Brain Findings of Thrombotic Changes in a Mouse Model
por: Ziporen, Lea, et al.
Publicado: (2004)

Close association between valvular heart disease and central nervous system manifestations in antiphospholipid syndrome
por: Krause, I, et al.
Publicado: (2005)

A Novel Dimeric Inhibitor Targeting Beta2GPI in Beta2GPI/Antibody Complexes Implicated in Antiphospholipid Syndrome
por: Kolyada, Alexey, et al.
Publicado: (2010)

Oxidation of beta(2)-glycoprotein I (beta(2)GPI) by the hydroxyl radical alters phospholipid binding and modulates recognition by anti-beta(2)GPI autoantibodies
por: Arvieux, J, et al.
Publicado: (2001)

Autoantibodies to GPI are predominantly present in extra-articular complications of human rheumatoid arthritis
por: van Gaalen, FA, et al.
Publicado: (2003)

Antiphospholipid Syndrome and Antibodies
por: de Carvalho, Jozélio Freire, et al.
Publicado: (2014)

Improving an anti-beta(2) GPI ELISA by reducing the influence of a blocking agent
por: Ambrozic, A, et al.
Publicado: (2001)

Eculizumab in recalcitrant antiphospholipid antibody syndrome
por: Zapantis, Ekaterini, et al.
Publicado: (2014)

Domain I of β2GPI is capable of blocking serum IgA antiphospholipid antibodies binding in vitro: an effect enhanced by PEGylation
por: Albay, A, et al.
Publicado: (2019)

The Role of TLR4 on B Cell Activation and Anti-β (2)GPI Antibody Production in the Antiphospholipid Syndrome
por: Cheng, Si, et al.
Publicado: (2016)

Acceleration of apoptotic cells clearance by macrophages upon exposure to serum amyloid P component and its synthetic derivates
por: Slutzky, L, et al.
Publicado: (2005)

Cerebrovascular insult and antiphospholipid antibodies in young adults
por: Cucnik, S, et al.
Publicado: (2002)

PredGPI: a GPI-anchor predictor
por: Pierleoni, Andrea, et al.
Publicado: (2008)

Coagulopathy triggered autoimmunity: experimental antiphospholipid syndrome in factor V Leiden mice
por: Katzav, Aviva, et al.
Publicado: (2013)

Isolation of beta2GPI by perchloric acid yields three proteins having different antigenic properties
por: Cucnik, S, et al.
Publicado: (2001)

Application Value of Combined Detection of Anti-β2-GPI, ACL, and Lupus Anticoagulant in the Diagnosis of Patients with Antiphospholipid Syndrome
por: Peng, Li, et al.
Publicado: (2022)

Antiphospholipid Antibodies: Their Origin and Development
por: Lackner, Karl J., et al.
Publicado: (2016)

Immunization with the glycolytic enzyme glucose-6-phosphate isomerase (GPI) induces peripheral polyarthritis in genetically unaltered mice
por: Schubert, D, et al.
Publicado: (2004)

Hydroxychloroquine partially prevents endothelial dysfunction induced by anti-beta-2-GPI antibodies in an in vivo mouse model of antiphospholipid syndrome
por: Urbanski, Geoffrey, et al.
Publicado: (2018)

Retracted: Application Value of Combined Detection of Anti-β2-GPI, ACL, and Lupus Anticoagulant in the Diagnosis of Patients with Antiphospholipid Syndrome
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Prothrombin fragment F1+2 in patients with antiphospholipid antibodies
por: Ambrozic, A, et al.
Publicado: (2004)

Do IgA antiphospholipid antibodies have any clinical importance?
por: Gaspersic, GN, et al.
Publicado: (2002)

P01-030 – Proteinuria in FMF – prediction of nephropathy type
por: Kukuy, OL, et al.
Publicado: (2013)

Infectome: A platform to trace infectious triggers of autoimmunity
por: Bogdanos, Dimitrios P., et al.
Publicado: (2013)

Low Folate Levels are Associated with Strokes and Less Venous Thromboses in Primary Antiphospholipid Syndrome
por: Carvalho, Jozélio Freire, et al.
Publicado: (2022)

Anti-β2GPI-domain I antibody is associated with extra-criteria manifestations in a large prospective antiphospholipid syndrome cohort in China
por: Zhou, Yangzhong, et al.
Publicado: (2023)

GPI-anchor and GPI-anchored protein expression in PMM2-CDG patients
por: de la Morena-Barrio, Maria E, et al.
Publicado: (2013)

Determinants of GPI-PLC Localisation to the Flagellum and Access to GPI-Anchored Substrates in Trypanosomes
por: Sunter, Jack, et al.
Publicado: (2013)

FT-GPI, a highly sensitive and accurate predictor of GPI-anchored proteins, reveals the composition and evolution of the GPI proteome in Plasmodium species
por: Sauer, Lena M., et al.
Publicado: (2023)

Elevated anti-serum amyloid P component (SAP) antibodies in SLE patients
por: Zandman-Goddard, G, et al.
Publicado: (2003)

A glycosylphosphatidylinositol (GPI)-negative phenotype produced in Leishmania major by GPI phospholipase C from Trypanosoma brucei: topography of two GPI pathways
Publicado: (1994)

Induction of apoptosis by polyamine metabolites in immunocompetent cells and different tumor cell lines
por: Lorenz, H-M, et al.
Publicado: (2002)

Antibodies to beta(2)-glycoprotein I, prothrombin and antithrombin III as markers of the antiphospholipid syndrome severity
por: Zabek, J, et al.
Publicado: (2001)

Accumulated precursors of specific GPI-anchored proteins upregulate GPI biosynthesis with ARV1
por: Liu, Yi-Shi, et al.
Publicado: (2023)

Antiphospholipid Antibodies Bind ATP: A putative Mechanism for the Pathogenesis of Neuronal Dysfunction
por: Chapman, J., et al.
Publicado: (2005)

The association of HLA-DR/DQ coding and QBP promoter allelic polymorphism with antiphospholipid antibody response in SLE
por: Logar, D, et al.
Publicado: (2002)

Efficacy and safety of the use of omalizumab in a patient with difficult-to-control severe asthma and antiphospholipid antibody syndrome
por: Villela, Rosangela, et al.
Publicado: (2015)

Structural analysis of the GPI glycan
por: Nakano, Miyako, et al.
Publicado: (2021)

GPI anchors: Regulated as needed
por: Aguilera-Romero, Auxiliadora, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qbms2latv3bprtc5ntcu7es72a